...
首页> 外文期刊>Vaccine >Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40l) in Pekin ducks.
【24h】

Immunogenicity and protective efficacy of a DNA vaccine encoding a chimeric protein of avian influenza hemagglutinin subtype H5 fused to CD154 (CD40l) in Pekin ducks.

机译:在北京鸭中编码与CD154(CD40l)融合的H5禽流感血凝素亚型嵌合蛋白的DNA疫苗的免疫原性和保护功效。

获取原文
获取原文并翻译 | 示例
           

摘要

The potential of CD154 (CD40L) as a powerful immunological adjuvant has been shown in various strategies. In this study we examine the immunogenicity and protective efficacy of a CD40-targeting avian influenza hemagglutinin (HA) subunit DNA vaccine in ducks. DNA constructs encoded the ectodomain of the HA protein of LPAI A/mallard/BC/373/2005 (H5N2) with or without fusion to the ectodomain of duck CD154. CD40-targeting significantly accelerated and enhanced humoral responses to the vector-encoded HA protein. In viral challenge experiments with A/chicken/Vietnam/14/2005 (H5N1), DNA immunization conferred partial protection against the genetically distant HPAI. The observed improved kinetics and magnitude of immune induction suggest that CD40-targeting holds promise for influenza A vaccine development.Digital Object Identifier http://dx.doi.org/10.1016/j.vaccine.2010.09.081
机译:CD154(CD40L)作为强大的免疫佐剂的潜力已在各种策略中得到证实。在这项研究中,我们研究了针对鸭的CD40靶向禽流感血凝素(HA)亚基DNA疫苗的免疫原性和保护功效。 DNA构建体编码LPAI A / mallard / BC / 373/2005(H5N2)HA蛋白的胞外域,带有或不融合到鸭CD154的胞外域。靶向CD40可以显着加速和增强对载体编码的HA蛋白的体液反应。在用A / chicken / Vietnam / 14/2005(H5N1)进行的病毒攻击实验中,DNA免疫赋予了针对遗传距离远的HPAI的部分保护。观察到的改善的免疫诱导动力学和强度表明CD40靶向有望为甲型流感疫苗的发展提供希望。数字对象标识符http://dx.doi.org/10.1016/j.vaccine.2010.09.081

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号